Source - LSE Regulatory
RNS Number : 0902E
Eden Research plc
05 July 2021
 

5 July 2021

 

 

Eden Research Plc

("Eden" or "Company")

Regulatory approval for Cedroz™ in Morocco and Mevalone® in Romania

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, announces that its bionematicide, Cedroz, has received authorisation for sale in Morocco and that its biofungicide, Mevalone, has received authorisation for sale in Romania.

Cedroz - Morocco

 

The approval in Morocco covers the use of Cedroz on tomatoes and cucumbers and is the first product authorisation for an Eden-developed product in this territory.

Tomatoes form a core part of Morocco's agricultural output, with the region producing around 565,000 tonnes of the crop per year, with sales representing 15.5% of the country's nominal Gross Domestic Product. Of this, Morocco exports around 33% of the tomatoes produced, with up to 90% consumed by the EU.

There is an increasing focus on Integrated Pest Management by the Moroccan Government, and a rising preference for the use of biofertilizers and biopesticides in both conventional and organic farming. As such, there is an opportunity for bio-nematicides, such as Cedroz, to address growing demands for the use of fewer synthetic chemical inputs and reduced residues in food. Cedroz will be distributed by Eden's regional commercial collaborator, Eastman Chemical Company, forming part of its Soil Care offering to farmers in Morocco, being an effective and sustainable solution to help fight nematodes, while ensuring harvested products meet export criteria and customer expectations for residue free crops.

Mevalone - Romania

 

In Romania, Mevalone is now approved for use on wine and table grapes. Romania is ranked as the sixth largest wine producer in Europe, where over 182,000 hectares of grapevines produce up to 5 million hectolitres of wine each year. A popular and widespread variety is Fetească regală, which is susceptible to botrytis.

The key export markets for Romanian wine are Germany and the UK, where consumers are becoming increasingly aware of the sustainability credentials of the wine they purchase. In a 2019 report by the Wine Market Council, 63% of respondents in the UK said that wine being produced sustainably was a purchasing consideration. The naturally derived ingredients in Mevalone mean it is well aligned with growers' needs in Romania and consumer expectations for sustainable, residue-free produce.

Sean Smith, Chief Executive Officer of Eden, commented: "We are delighted by these new authorisations, which represent the first approval of Eden-developed products in the Moroccan and Romania markets, led by our commercial collaborators, Eastman and KNE Certis, respectively. With governments in these countries focused on reducing the use of conventional chemicals in agriculture, these developments represent exciting opportunities for us, as farmers seek sustainable and effective alternatives. Cedroz has now been authorised in ten countries and Mevalone in fourteen and we look forward to working alongside our commercial partners to expand our products' footprints in the growing biopesticides market."

For further information contact:

Eden Research plc

www.edenresearch.com

Sean Smith
Alex Abrey

01285 359 555

 

 

Cenkos Securities plc (Nominated advisor and broker)

 

Giles Balleny / Camilla Hume/ Mark Connelly (corporate finance)
Michael Johnson (sales)

020 7397 8900

 

 

Hawthorn Advisors (Financial PR)

 

Victoria Ainsworth
Johanna Pemberton

eden@hawthornadvisors.com

 

 

Notes to Editors:

 

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has two products currently on the market:

Mevalone® is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops.  It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.

Cedroz is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally.  Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.

Eden's Sustaine® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

For more information about Eden, please visit: www.edenresearch.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAMZGGNZDGGMZZ
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Eden Research PLC (EDEN)

0p (0.00%)
delayed 08:12AM